Skip to main content
. 2020 Jun 29;2(1):vdaa077. doi: 10.1093/noajnl/vdaa077

Figure 4.

Figure 4.

No patients who had a bone marrow transplant died during the follow-up period (overall survival [OS] censoring times for the 6 transplant patients ranged from 8.8 to 26.7 months). In 23 nontransplant patients, the median OS was 67.1 months (95% CI: 10.5–NR) without vincristine and was 85.3 months (95% CI: 6.6–85.3) with vincristine.